This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Edward Albert Munn: Innovator in Vaccine Development
Introduction
Edward Albert Munn, located in Fulbourn, Cambridge, is a notable inventor recognized for his contributions to the field of vaccine development. With a focus on addressing parasitic infections, Munn has made significant strides in understanding and creating effective solutions against these challenges. His work embodies the dedication and innovation that characterize successful inventors in the scientific community.
Latest Patents
Munn holds one patent, which describes a vaccine containing a unique protein complex derived from Haemonchus contortus, a parasitic nematode. This protein complex, termed H45, consists of glycoproteins that are isolable from the intestinal microvillus plasma membrane of the parasite. The components of this complex include protein H4.5, identifiable by its molecular weight of about 45 Kd under reducing conditions and about 90 Kd under non-reducing conditions on sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Additionally, proteins H4.9 and H5.3, having molecular weights of about 49 Kd and 53 Kd, respectively, are also part of this formulation. Remarkably, the H45 protein complex can significantly reduce the weight of worms in sheep infected with Haemonchus contortus by an average of 91%, as well as decrease parasite egg production by an impressive average of 94.5%.
Career Highlights
Throughout his career, Edward Munn has demonstrated exceptional ingenuity and persistence in his research endeavors. His work on the H45 protein complex showcases not only his scientific acumen but also a commitment to advancing veterinary health solutions. Munn's contributions are vital in developing vaccines that can amplify the health and productivity of livestock.
Collaborations
In his continuous journey towards innovation, Munn has collaborated with Trevor Stanley Smith, working together to enhance the potential impact of their research. Such collaborations are essential in the realm of scientific discovery, where combined expertise often leads to groundbreaking results.
Conclusion
Edward Albert Munn stands out as a profound contributor to the field of vaccine development against parasitic infections. His innovative approach in creating the H45 protein complex serves as a testament to the importance of research and development in improving agricultural health solutions. As the landscape of scientific inquiry continues to evolve, Munn's work emphasizes the ongoing need for innovations that address real-world challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile